BACKGROUND: Although resection historically played a prominent role in the treatment of metastatic melanoma, recent advances have altered the therapeutic landscape, and potentially the role of surgery. We examined surgical selection and metastasectomy outcomes before and after the onset of the effective drug therapy era. METHODS: Patients with stage IV melanoma were identified and characterized by treatment era (either 1965-2007 or 2008-2015) and by systemic therapy agents. BRAF and/or MEK inhibitors, as well as checkpoint inhibitors, were included as modern agents. Selection factors for metastasectomy were examined by era. A matched-pair analysis of outcomes of surgical and non-surgical patients receiving modern systemic agents was perform...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
The survival of advanced metastatic melanoma has been greatly improved within the past few years. Ne...
BACKGROUND: The development of brain metastases is common for systemic treatment failure in patients...
BACKGROUND: Although resection historically played a prominent role in the treatment of metastatic m...
BACKGROUND: For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery i...
Systemic therapy for metastatic melanoma has evolved rapidly during the last decade, and patient tre...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
Opportunities for surgical treatment in metastatic melanoma patients have re-emerged due to the deve...
Opportunities for surgical treatment in metastatic melanoma patients have re-emerged due to the deve...
Hypothesis :The clinical treatment of patients with stage IV melanoma according to criteria of the A...
In melanoma, about 1 in 5 patients develops distant metastases and suffers a very poor prognosis. Co...
In melanoma, about 1 in 5 patients develops distant metastases and suffers a very poor prognosis. Co...
Successful systemic management of stage IV melanoma continues to be elusive because of the paucity o...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
The survival of advanced metastatic melanoma has been greatly improved within the past few years. Ne...
BACKGROUND: The development of brain metastases is common for systemic treatment failure in patients...
BACKGROUND: Although resection historically played a prominent role in the treatment of metastatic m...
BACKGROUND: For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery i...
Systemic therapy for metastatic melanoma has evolved rapidly during the last decade, and patient tre...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
Opportunities for surgical treatment in metastatic melanoma patients have re-emerged due to the deve...
Opportunities for surgical treatment in metastatic melanoma patients have re-emerged due to the deve...
Hypothesis :The clinical treatment of patients with stage IV melanoma according to criteria of the A...
In melanoma, about 1 in 5 patients develops distant metastases and suffers a very poor prognosis. Co...
In melanoma, about 1 in 5 patients develops distant metastases and suffers a very poor prognosis. Co...
Successful systemic management of stage IV melanoma continues to be elusive because of the paucity o...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
The survival of advanced metastatic melanoma has been greatly improved within the past few years. Ne...
BACKGROUND: The development of brain metastases is common for systemic treatment failure in patients...